BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a product name.
BioCentury | Aug 8, 2016
Clinical News

Lenzilumab: Phase I started

BioCentury | Dec 22, 2015
Clinical News

UC Davis delays KaloBios trial on Shkreli news

BioCentury | Nov 20, 2015
Financial News

Shkreli investment gives KaloBios lifeline

BioCentury | Nov 16, 2015
Company News

KaloBios cancer news

BioCentury | Jan 7, 2015
Clinical News

KaloBios drops CF progam after Phase II miss

BioCentury | Feb 3, 2014
Clinical News

KB003: Development discontinued

BioCentury | Feb 3, 2014
Analyst Picks & Changes

Analyst picks & changes

BioCentury | Feb 3, 2014
Finance

Highlights of weekly biotech stock moves

Regulatory, clinical and other milestones
BioCentury | Jan 30, 2014
Clinical News

KaloBios falls after dropping KB003 for asthma

Items per page:
1 - 10 of 26